BioSpace News Archive

Prelude Corporation, a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced that it has closed a $20 million funding round led by Evidity Health Capital and joined by existing and new investors.

Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a fireside chat and one-on-one investor meetings at the Maxim Virtual Growth Conference, to be held March 28-30, 2022.

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today announced the appointment of Molly Henderson to the position of Chief Financial and Business Officer.

Conformis, Inc., the pioneer and leader of fully personalized knee and hip replacement systems, announced a strategic marketing partnership with Synchrony that will add the innovative Image-to-Implant® Platinum Services℠ Program to Synchrony’s successful CareCredit offering.

Daré Bioscience, Inc. today announced that Sabrina Martucci Johnson, its President and CEO, will participate in the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, being held March 28-30, 2022.

BioSig Technologies, Inc. announced that it entered in a definitive purchase agreement for the sale of $3 million of the Company’s common stock and warrants lead by a family office that has deep expertise in small cap emerging growth investing.

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it has discontinued development of its drug candidate, ALG-020572, which was being studied in subjects with chronic hepatitis B (CHB).

Aileron Therapeutics announced that Manuel Aivado, M.D., Ph.D., President and Chief Executive Officer, will provide a company overview at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, which will take place March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT.

Respira Technologies, Inc. announced , its partnership with the Plough Center for Sterile Drug Delivery at the University of Tennessee Health Science Center to execute aseptic drug product handling and cartridge filling to support the companies planned IND submission to the FDA and to prepare for human clinical studies.

Smith+Nephew, the global medical technology business, announces it will it showcase its latest innovations for Orthopaedic Reconstruction and Robotics during the American Academy of Orthopaedic Surgeons 2022 Annual Meeting being held in Chicago, IL.